Related Experiment Video
Updated: Mar 10, 2026

14:59
Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
11.3K
Visual Outcomes from Shunting for Idiopathic Intracranial Hypertension
S J Hickman1, N Raoof2, H Panesar3
1Department of Neurology, Royal Hallamshire Hospital Sheffield UK.
Neuro-Ophthalmology (Aeolus Press)
|December 9, 2016
Summary
Shunt surgery for idiopathic intracranial hypertension (IIH) improved vision in patients. However, complications and persistent headaches were common, highlighting the need for further research and randomized controlled trials.
Area of Science:
- Ophthalmology
- Neurosurgery
- Neurology
Background:
- Idiopathic intracranial hypertension (IIH) is a condition characterized by increased intracranial pressure without a clear cause.
- Visual impairment is a significant complication of IIH, necessitating effective treatment strategies.
Purpose of the Study:
- To evaluate the effectiveness of shunt surgery in improving visual function in patients with IIH.
- To assess the complication rates and long-term outcomes, including headache persistence, following shunt procedures for IIH.
Main Methods:
- A retrospective review of 50 patients who underwent shunt surgery for IIH.
- Measurement of decimal visual acuity and Goldmann visual field mean radial degrees (MRD) pre-operatively and post-operatively (mean follow-up: 1123 days).
- Analysis of shunt types (ventriculo-peritoneal vs. lumbo-peritoneal), number of procedures, complications, and persistent symptoms.
Main Results:
- Significant improvement in mean decimal visual acuity (0.75 to 0.84, p=0.011) and MRD (25.6° to 35.5°, p<0.0001) in the worse affected eye.
- Patients with significant pre-operative visual impairment (MRD ≤30°) showed marked MRD improvement (10.3° to 26.5°, p=0.0008).
- High complication rate (30/50 patients) and need for multiple procedures (mean 2.8 per patient); headache persisted in 28 patients.
Conclusions:
- Shunt surgery can effectively improve visual function in patients diagnosed with IIH.
- Significant post-operative morbidity, frequent need for revision surgeries, and persistent headaches are considerable challenges.
- Further investigation through randomized controlled trials is warranted to optimize operative interventions for IIH, particularly for vision loss.
Keywords:
Idiopathic intracranial hypertensionlumboperitoneal shuntventriculoperitoneal shuntvisual fieldsMore Related Videos
Related Concept Videos
Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Angle Closure Glaucoma: Treatment
1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K

